CHO technology speeds up productivity
Developments in the field of Chinese Hamster Ovary (CHO) based biomanufacturing this week with new products from SAFC and BD Biosciences.
New synthetic cell membranes set to cut time and costs
Costly and time consuming drug screening could soon be a thing of the past thanks to new easy-bake synthetic cell membranes made at the Institute of Materials Research and Engineering (IMRE).
UBC's vision for new diabetic retinopathy delivery device
Scientists at the University of British Columbia have pioneered a magnetic retinal implant that can supply a regulated and on-demand release of drugs to treat blindness from diabetic retinopathy.
WTO rules against China in raw material export quota case
A WTO panel has ruled China’s export limits on raw materials, including some with pharma uses, are unfair after claims they drive up prices.
Second partnership for Fujifilm and Mitsubishi
Fujifilm and Mitsubishi have embarked on a joint business venture in the contract manufacturing for biopharmaceuticals.
EMA OK for second Shire Replagal plant
Shire has received European Medicines Agency (EMA) approval for a new US plant, doubling purification capacity for its Fabry disease drug Replagal.
Appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
DSM adds single-step purification and polishing technique for bioproduction
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
BioMarin to buy Pfizer’s Shanbally biologics plant
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Neuland to launch commercial-scale peptide manufacturing
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Pall expands Allegro mixer range
Processing technology firm Pall Life Sciences has introduced a 200L version of its Allegro single-use mixer for biopharmaceutical manufacturing.
Catalent and Cevec team on cell line development platform
Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
Mystic awarded key manufacturing patent for delivery tech
Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.
NeoStem’s China antibiotics unit gets expanded SFDA approval
US stem-cell therapy firm NeoStem predicts that output of its China-based generic antibiotics subsidiary Suzhou Erye Pharmaceutical will increase after further manufacturing approval from the SFDA.
SSB and Sudpack team on plastic films for biologics production
Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.